BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31620947)

  • 1. Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation.
    Shah AJ; Sokolic R; Logan B; Yin Z; Iyengar S; Scalchunes C; Mangurian C; Albert M; Cowan MJ
    J Clin Immunol; 2019 Nov; 39(8):786-794. PubMed ID: 31620947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in children with chronic immune thrombocytopenia in China.
    Zhang H; Wang L; Quan M; Huang J; Wu P; Lu Q; Fang Y
    Health Qual Life Outcomes; 2016 Mar; 14():45. PubMed ID: 26979950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
    Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
    Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Crestani E; Volpi S; Candotti F; Giliani S; Notarangelo LD; Chu J; Aldave Becerra JC; Buchbinder D; Chou J; Geha RS; Kanariou M; King A; Mazza C; Moratto D; Sokolic R; Garabedian E; Porta F; Putti MC; Wakim RH; Tsitsikov E; Pai SY; Notarangelo LD
    J Allergy Clin Immunol; 2015 Nov; 136(5):1401-4.e1-3. PubMed ID: 26409660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene.
    Oshima K; Imai K; Albert MH; Bittner TC; Strauss G; Filipovich AH; Morio T; Kapoor N; Dalal J; Schultz KR; Casper JT; Notarangelo LD; Ochs HD; Nonoyama S
    J Clin Immunol; 2015 Jan; 35(1):15-21. PubMed ID: 25388447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia.
    Hoshino A; Shimizu M; Matsukura H; Sakaki-Nakatsubo H; Nomura K; Miyawaki T; Kanegane H
    J Clin Immunol; 2014 Jan; 34(1):53-7. PubMed ID: 24217816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of clinical presentations and two novel mutations in patients with Wiskott-Aldrich syndrome/X-linked Thrombocytopenia.
    Udomkittivorakul N; Wattanasirichaigoon D; Manuyakorn W; Pongphitcha P; Khongkraparn A; Tunlayadechanont P; Sirachainan N
    Platelets; 2022 Jul; 33(5):792-796. PubMed ID: 34705590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, Laboratory Features and Clinical Courses of Patients with Wiskott Aldrich Syndrome and X-linked Thrombocytopenia-A single center study.
    Bildik HN; Cagdas D; Ozturk Kura A; Oskay Halacli S; Sanal O; Tezcan I
    Immunol Invest; 2022 Jul; 51(5):1272-1283. PubMed ID: 34098853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
    Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How I manage patients with Wiskott Aldrich syndrome.
    Rivers E; Worth A; Thrasher AJ; Burns SO
    Br J Haematol; 2019 May; 185(4):647-655. PubMed ID: 30864154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.
    Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V;
    Haematologica; 2017 Jun; 102(6):1112-1119. PubMed ID: 28255019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
    Ozsahin H; Le Deist F; Benkerrou M; Cavazzana-Calvo M; Gomez L; Griscelli C; Blanche S; Fischer A
    J Pediatr; 1996 Aug; 129(2):238-44. PubMed ID: 8765621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
    Andreu N; Matamoros N; Escudero A; Fillat C
    Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life following hematopoietic stem cell transplant during childhood.
    Nuss SL; Wilson ME
    J Pediatr Oncol Nurs; 2007; 24(2):106-15. PubMed ID: 17332424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
    Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
    J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated donor BMT for Wiskott-Aldrich syndrome.
    Lenarsky C; Weinberg K; Kohn DB; Parkman R
    Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype.
    Linder S; Wintergerst U; Bender-Götze C; Schwarz K; Pannicke U; Aepfelbacher M
    Immunol Cell Biol; 2003 Apr; 81(2):130-6. PubMed ID: 12631236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA Nephropathy Complicated with X-linked Thrombocytopenia.
    Kakio Y; Uchida HA; Kitagawa M; Arata Y; Kato A; Inoue-Torii A; Hinamoto N; Ogawa-Akiyama A; Sugiyama H; Wada J
    Acta Med Okayama; 2018 Jun; 72(3):301-307. PubMed ID: 29926009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
    Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.